Please login to the form below

Not currently logged in
Email:
Password:

Ian Weatherhead joins Ipsen

Takes up corporate communications role at the French pharma firm

Ipsen Dr Ian WeatherheadFrench biopharmaceutical company Ipsen has appointed Ian Weatherhead as vice president, corporate external communications.

He brings 20 years of corporate communications experience within the life sciences sector, most recently at Teva UK/Ireland where he led its corporate communications and government affairs team.

Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.

In his new role at Ipsen Weatherhead will be responsible for the design and implementation of an external corporate communications strategy.

Reporting to senior vice president, public affairs and

corporate communications Didier Veron, Weatherhead will also oversee Ipsen’s media and public relations, digital communications, and corporate image and reputation.

Veron said: “I am delighted that Ian is joining the team to advance our external communications strategy as Ipsen continues its evolution into a leading global biopharmaceutical company focused on innovation and specialty care. He brings a wealth of experience in the pharmaceutical sector.”

13th September 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics